open access

Vol 68, No 1 (2010)
Other
Published online: 2010-02-03
Submitted: 2012-12-28
Get Citation

Original article
Complimentary roles for N-terminal pro-B-type natriuretic peptide and spirometry to assess functional capacity in patients with complex mixed heart valve disease

Naylin Bissessor, Yong Shen Wee, Rohan Jayasinghe, Irene Zeng, Boris Lowe, John Kolbe, Kevin Ellyet, Andrew Kerr, Harvey White, Ralph Stewart
Kardiol Pol 2010;68(1):1-10.

open access

Vol 68, No 1 (2010)
Other
Published online: 2010-02-03
Submitted: 2012-12-28

Abstract

Background: Assessing the effects of valvular heart disease on functional capacity is important for optimal timing of surgery.
Aim: To determine whether N-terminal pro-B type natriuretic peptide (NT-proBNP) and lung spirometry predict maximum oxygen consumption (pVO2) on cardio-pulmonary exercise testing in patients with mixed heart valve disease.
Methods: Forty-five clinically stable patients with moderate-severe stenosis and/or regurgitation of the aortic, mitral and/or tricuspid valves were studied. The ability of echocardiography, NT-proBNP, forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) to predict impaired pVO2 was determined.
Results: On univariate analysis the natural logarithm of NT-proBNP explained more of the variation in pVO2 (r2 = 0.40, p < 0.0001) than valve severity score (r2 = 0.20, p = 0.002), pulmonary artery pressure (r2 = 0.21, p = 0.005), left atrial area index (r2 = 0.25, p = 0.001) or LV ejection fraction (r2 = 0.02, p = 0.4). Low lean body weight (r2 = 0.21, p = 0.002), FEV1 (r2 = 0.26, p = 0.0003) and FVC (r2 = 0.20, p = 0.002) were also associated with pVO2. In multi-variable analysis independent determinants of pVO2 were NT-proBNP (r2 = 0.27, p = 0.001), FVC (r2 = 0.20, p = 0.0002) and lean body weight (r2 = 0.23, p = 0.001). NT-proBNP and FVC together were better predictors of pVO2 < 60% (C statistic = 0.83, 95% CI 0.71, 0.95) than either NT-proBNP (C = 0.80, 95% CI 0.66, 0.94) or FVC (C =0.73, 95% CI 0.57, 0.89) alone. NT-proBNP, FVC and age also predicted excessive ventilation on cardio-pulmonary exercise (combined r2 = 0.54, p < 0.0001).
Conclusion: In patients with mixed heart valve disease NT-proBNP and spirometry provide a more reliable assessment of functional capacity than assessment by echocardiography and symptoms alone.

Abstract

Background: Assessing the effects of valvular heart disease on functional capacity is important for optimal timing of surgery.
Aim: To determine whether N-terminal pro-B type natriuretic peptide (NT-proBNP) and lung spirometry predict maximum oxygen consumption (pVO2) on cardio-pulmonary exercise testing in patients with mixed heart valve disease.
Methods: Forty-five clinically stable patients with moderate-severe stenosis and/or regurgitation of the aortic, mitral and/or tricuspid valves were studied. The ability of echocardiography, NT-proBNP, forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) to predict impaired pVO2 was determined.
Results: On univariate analysis the natural logarithm of NT-proBNP explained more of the variation in pVO2 (r2 = 0.40, p < 0.0001) than valve severity score (r2 = 0.20, p = 0.002), pulmonary artery pressure (r2 = 0.21, p = 0.005), left atrial area index (r2 = 0.25, p = 0.001) or LV ejection fraction (r2 = 0.02, p = 0.4). Low lean body weight (r2 = 0.21, p = 0.002), FEV1 (r2 = 0.26, p = 0.0003) and FVC (r2 = 0.20, p = 0.002) were also associated with pVO2. In multi-variable analysis independent determinants of pVO2 were NT-proBNP (r2 = 0.27, p = 0.001), FVC (r2 = 0.20, p = 0.0002) and lean body weight (r2 = 0.23, p = 0.001). NT-proBNP and FVC together were better predictors of pVO2 < 60% (C statistic = 0.83, 95% CI 0.71, 0.95) than either NT-proBNP (C = 0.80, 95% CI 0.66, 0.94) or FVC (C =0.73, 95% CI 0.57, 0.89) alone. NT-proBNP, FVC and age also predicted excessive ventilation on cardio-pulmonary exercise (combined r2 = 0.54, p < 0.0001).
Conclusion: In patients with mixed heart valve disease NT-proBNP and spirometry provide a more reliable assessment of functional capacity than assessment by echocardiography and symptoms alone.
Get Citation

Keywords

mitral valve; aortic valve; spirometry; BNP; cardio-pulmonary testing

About this article
Title

Original article
Complimentary roles for N-terminal pro-B-type natriuretic peptide and spirometry to assess functional capacity in patients with complex mixed heart valve disease

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 68, No 1 (2010)

Pages

1-10

Published online

2010-02-03

Bibliographic record

Kardiol Pol 2010;68(1):1-10.

Keywords

mitral valve
aortic valve
spirometry
BNP
cardio-pulmonary testing

Authors

Naylin Bissessor
Yong Shen Wee
Rohan Jayasinghe
Irene Zeng
Boris Lowe
John Kolbe
Kevin Ellyet
Andrew Kerr
Harvey White
Ralph Stewart

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl